Page 76 - Read Online

Page 16 of 18 Lee et al. J Cancer Metastasis Treat 2021;7:27 https://dx.doi.org/10.20517/2394-4722.2021.58

83. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of stem cell genes guides creation of epithelial cancer
stem cells. Cell Stem Cell 2008;2:333-44. DOI PubMed PMC
84. Kim J, Woo AJ, Chu J, et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription
programs. Cell 2010;143:313-24. DOI PubMed PMC
85. Efroni S, Duttagupta R, Cheng J, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008;2:437-47. DOI
PubMed PMC
86. Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells.
Cell 2006;125:315-26. DOI PubMed
87. Azuara V, Perry P, Sauer S, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006;8:532-8. DOI PubMed
88. Gan Q, Yoshida T, McDonald OG, Owens GK. Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage
determination of embryonic stem cells. Stem Cells 2007;25:2-9. DOI PubMed
89. Mikkelsen TS, Ku M, Jaffe DB, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature
2007;448:553-60. DOI PubMed PMC
90. Lee WK, Hwang S, Kim D, et al. Distinct features of nonthyroidal illness in critically ill patients with infectious diseases. Medicine
(Baltimore) 2016;95:e3346. DOI PubMed PMC
91. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-304. DOI PubMed
92. Méndez-Pertuz M, Sánchez-Pacheco A, Aranda A. The thyroid hormone receptor antagonizes CREB-mediated transcription. EMBO
J 2003;22:3102-12. DOI PubMed PMC
93. Rogatsky I, Zarember KA, Yamamoto KR. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response
element that mediates regulation by phorbol esters and hormones. EMBO J 2001;20:6071-83. DOI PubMed PMC
94. Kim WG, Cheng SY. Thyroid hormone receptors and cancer. Biochim Biophys Acta 2013;1830:3928-36. DOI PubMed PMC
95. Li Z, Meng ZH, Chandrasekaran R, et al. Biallelic inactivation of the thyroid hormone receptor β1 gene in early stage breast cancer.
Cancer Res 2002;62:1939-43. PubMed
96. Iwasaki Y, Sunaga N, Tomizawa Y, et al. Epigenetic inactivation of the thyroid hormone receptor β1 gene at 3p24. 2 in lung cancer.
Ann Surg Oncol 2010;17:2222-8. DOI PubMed
97. Joseph B, Ji M, Liu D, Hou P, Xing M. Lack of mutations in the thyroid hormone receptor (TR) α and β genes but frequent
hypermethylation of the TR β gene in differentiated thyroid tumors. J Clin Endocrinol Metab 2007;92:4766-70. DOI PubMed
98. Dunwell TL, Hesson LB, Pavlova TV, et al. Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 2009;4:185-
93. DOI PubMed
99. Hörkkö TT, Tuppurainen K, George SM, Jernvall P, Karttunen TJ, Mäkinen MJ. Thyroid hormone receptor β1 in normal colon and
colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. Int J Cancer 2006;118:1653-9. DOI
PubMed
100. Kim WG, Zhao L, Kim DW, Willingham MC, Cheng SY. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft
models. Thyroid 2014;24:260-9. DOI PubMed PMC
101. Kim WG, Zhu X, Kim DW, Zhang L, Kebebew E, Cheng SY. Reactivation of the silenced thyroid hormone receptor β gene
expression delays thyroid tumor progression. Endocrinology 2013;154:25-35. DOI PubMed PMC
102. Jazdzewski K, Boguslawska J, Jendrzejewski J, et al. Thyroid hormone receptor β (THRB) is a major target gene for microRNAs
deregulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab 2011;96:E546-53. DOI PubMed PMC
103. Suzuki H, Willingham MC, Cheng SY. Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid
carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 2002;12:963-9. DOI PubMed
104. Guigon C, Kim D, Willingham M, Cheng S. Mutation of thyroid hormone receptor-β in mice predisposes to the development of
mammary tumors. Oncogene 2011;30:3381-90. DOI PubMed PMC
105. Furumoto H, Ying H, Chandramouli G, et al. An unliganded thyroid hormone β receptor activates the cyclin D1/cyclin-dependent
kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 2005;25:124-35. DOI PubMed PMC
106. Kato Y, Ying H, Willingham MC, Cheng SY. A tumor suppressor role for thyroid hormone β receptor in a mouse model of thyroid
carcinogenesis. Endocrinology 2004;145:4430-8. DOI PubMed
107. Zhu XG, Zhao L, Willingham MC, Cheng SY. Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic
follicular thyroid carcinoma. Oncogene 2010;29:1909-19. DOI PubMed PMC
108. Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med
2014;4:a014241. DOI PubMed PMC
109. Haugen D, Akslen L, Varhaug J, Lillehaug J. Demonstration of a TGF-α-EGF-receptor autocrine loop and c-myc protein over-
expression in papillary thyroid carcinomas. Int J Cancer 1993;55:37-43. DOI PubMed
110. Enomoto K, Zhu X, Park S, et al. Targeting MYC as a therapeutic intervention for anaplastic thyroid cancer. J Clin Endocrinol Metab
2017;102:2268-80. DOI PubMed PMC
111. Terrier P, Sheng Z, Schlumberger M, et al. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. Br J
Cancer 1988;57:43-7. DOI PubMed PMC
112. Romano M, Grattone M, Karner M, et al. Relationship between the level of c-myc mRNA and histologic aggressiveness in thyroid
tumors. Horm Res Paediatr 1993;39:161-5. DOI PubMed
113. Zhu X, Zhao L, Park JW, Willingham MC, Cheng SY. Synergistic signaling of KRAS and thyroid hormone receptor β mutants
promotes undifferentiated thyroid cancer through MYC up-regulation. Neoplasia 2014;16:757-69. DOI PubMed PMC
114. Soucek L, Whitfield JR, Sodir NM, et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev